Form 8-K - Current report:
SEC Accession No. 0001193125-23-270432
Filing Date
2023-11-03
Accepted
2023-11-03 16:30:57
Documents
13
Period of Report
2023-11-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d583587d8k.htm   iXBRL 8-K 25062
2 EX-99.1 d583587dex991.htm EX-99.1 9916
  Complete submission text file 0001193125-23-270432.txt   164800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20231102.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20231102_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20231102_pre.xml EX-101.PRE 11725
7 EXTRACTED XBRL INSTANCE DOCUMENT d583587d8k_htm.xml XML 3526
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 231376840
SIC: 2834 Pharmaceutical Preparations